Endomedix INC
At a glance
Employees1-19
In business sinceNot reported
HeadquartersMontclair, NJ
US patents13
SAM.gov UEIDKP6MYX4J176
CAGE code4H1S1
Incorporated inDE
Supplier designations
For Profit Organization
Self-certified by the company in its SAM.gov registration
Patents
13 US patents granted 1992–2024, 2 of them in the five years to SEP 2025.
Medical technology 9Pharmaceuticals 4
- Methods and compositions for achieving hemostasis and stable blood clot formationUS 12,091,471 · granted SEP 17, 2024
- Methods and compositions for achieving hemostasis and stable blood clot formationUS 11,033,654 · granted JUN 15, 2021
- Methods and compositions for achieving hemostasis and stable blood clot formationUS 10,517,988 · granted DEC 31, 2019
- Biopolymer system for tissue sealingUS 9,731,044 · granted AUG 15, 2017
- Biopolymer system for tissue sealingUS 9,259,434 · granted FEB 16, 2016
Newest 5 shown · Granted to Endomedix, Inc. · PatentsView (USPTO), data through SEP 30, 2025 · CC BY 4.0
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Endomedix INC | Montclair | NJ | 1–19 | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.